Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Mar 17;120(6):960-977.
doi: 10.1161/CIRCRESAHA.116.309048.

Neurodevelopmental Abnormalities and Congenital Heart Disease: Insights Into Altered Brain Maturation

Affiliations
Review

Neurodevelopmental Abnormalities and Congenital Heart Disease: Insights Into Altered Brain Maturation

Paul D Morton et al. Circ Res. .

Abstract

In the past 2 decades, it has become evident that individuals born with congenital heart disease (CHD) are at risk of developing life-long neurological deficits. Multifactorial risk factors contributing to neurodevelopmental abnormalities associated with CHD have been identified; however, the underlying causes remain largely unknown, and efforts to address this issue have only recently begun. There has been a dramatic shift in focus from newly acquired brain injuries associated with corrective and palliative heart surgery to antenatal and preoperative factors governing altered brain maturation in CHD. In this review, we describe key time windows of development during which the immature brain is vulnerable to injury. Special emphasis is placed on the dynamic nature of cellular events and how CHD may adversely impact the cellular units and networks necessary for proper cognitive and motor function. In addition, we describe current gaps in knowledge and offer perspectives about what can be done to improve our understanding of neurological deficits in CHD. Ultimately, a multidisciplinary approach will be essential to prevent or improve adverse neurodevelopmental outcomes in individuals surviving CHD.

Keywords: brain; models, animal; neuroimaging; risk factors.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Severity of congenital heart disease positively correlates with increased incidence of neurological impairments. Reprinted from Wernovsky. Copyright © 2006 Cambridge University Press.
Figure 2
Figure 2
(A) Cortical gyrification increases throughout fetal and perinatal brain development. w, weeks. Legend demarks the four lobes of the cortex. (B) Gyrification indices and cortical surface areas of fetuses with HLHS compared with normal fetuses. Adapted from Dubois and Dehaene-Lambertz (A) and Clouchoux et al. (B), with permission from Elsevier.
Figure 3
Figure 3
Risk factors (A) associated with neurodevelopmental outcomes in CHD during progressive epochs of brain development (B). Adapted from Morton et al., with permission from Elsevier.
Figure 4
Figure 4
(A) 3D reconstruction of the corpus callosum of a neonatal piglet defined by tractography with DTI. Immunostains illuminating the oligodendroctye (OL) lineage 3 days (B–E) and 4 weeks (F,J) following severe CPB. 3 days following severe-CPB, OPCs (Mash1+ (B), PDGFRα+ (C)) and mature OLs (CC1+ (E)) display resilience to the surgical insult, whereas pre-OLs (O4+) are susceptible to programmed cell death (Casp3+ (D)) in the corpus callosum (CC) – a WM tract connecting the left and right hemisphere of the brain. Severe-CPB results in fewer mature OLs (F,J) and less myelin basic protein (MBP) (G,K) in the CC, 1 month following surgery. Severe-CPB also results in an increase in the number of microglia (Iba1+) in the CC (H,L), 3 days after surgery. (G,M) Astrocytic response in a mouse brain slice model of CPB. Three hours after oxygen-glucose deprivation (OGD) at 15°C WM astrocytes (GFAP-GFP+) in the CC display a distinct change in morphology (M compared to I). Scale bars, 50 μm (B–M). Adapted from Morton et al., with permission from Elsevier.

References

    1. Gilboa SM, Salemi JL, Nembhard WN, Fixler DE, Correa A. Mortality resulting from congenital heart disease among children and adults in the united states, 1999 to 2006. Circulation. 2010;122:2254–2263. - PMC - PubMed
    1. Moller JH, Taubert KA, Allen HD, Clark EB, Lauer RM. Cardiovascular health and disease in children: Current status. A special writing group from the task force on children and youth, american heart association. Circulation. 1994;89:923–930. - PubMed
    1. Marelli AJ, Ionescu-Ittu R, Mackie AS, Guo L, Dendukuri N, Kaouache M. Lifetime prevalence of congenital heart disease in the general population from 2000 to 2010. Circulation. 2014;130:749–756. - PubMed
    1. Marino BS, Lipkin PH, Newburger JW, Peacock G, Gerdes M, Gaynor JW, Mussatto KA, Uzark K, Goldberg CS, Johnson WH, Jr, Li J, Smith SE, Bellinger DC, Mahle WT. Neurodevelopmental outcomes in children with congenital heart disease: Evaluation and management: A scientific statement from the american heart association. Circulation. 2012;126:1143–1172. - PubMed
    1. Bellinger DC, Wypij D, Rivkin MJ, DeMaso DR, Robertson RL, Jr, Dunbar-Masterson C, Rappaport LA, Wernovsky G, Jonas RA, Newburger JW. Adolescents with d-transposition of the great arteries corrected with the arterial switch procedure: Neuropsychological assessment and structural brain imaging. Circulation. 2011;124:1361–1369. - PMC - PubMed

MeSH terms